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Abstract
Background: The early use of blood products has been associated with improved patient outcomes following
severe hemorrhage or traumatic injury. We aimed to investigate the influence of pre-hospital blood products (i.e.
plasma and/or RBCs) on admission hemostatic properties and patient outcomes. We hypothesized that
pre-hospital plasma would improve hemostatic function as evaluated by rapid thrombelastography (rTEG).
Methods: We conducted a prospective observational study recruiting 257 trauma patients admitted to a Level I
trauma center having received either blood products pre-hospital or in-hospital within 6 hours of admission. Clinical
data on patient demographics, blood biochemistry, injury severity score and mortality were collected. Admission
rTEG was conducted to characterize the coagulation profile and hemostatic function.
Results: 75 patients received pre-hospital plasma and/or RBCs (PH group; nearly half received both RBCs and plasma)
whereas 182 patients only received in-hospital blood products (RBCs, Plasma and Platelets) within 6 hours of admission
(IH group). PH patients had lower Glasgow coma scale (GCS) scores, more penetrating injuries, lower systolic blood
pressures, lower hemoglobin levels, lower platelet counts and greater acidosis upon ED admission than the IH group
(all p < 0.05). Despite differences in type of injury and admission vitals indicating that the PH group had more signs of
bleeding than the IH group, there were no significant differences in in-hospital mortality (PH 26.7% vs. IH 20.9% p = 0.
31). When comparing rTEG variables between PH patients transfused with 0, 1 or 2 units of plasma, more pre-hospital
plasma transfusion was tendency towards improved rTEG variables. When adjusting for pre-hospital RBC, pre-hospital
plasma was associated with significantly higher rTEG MA (p = 0.012) at hospital admission.
Discussion: After adjusting for pre-hospital RBCs, pre-hospital plasma transfusion was independently associated with
increased rTEG MA, as well as arrival indices of shock and hemodynamic instability. Besides more severe injury and
worse clinical presentation, the group that received pre-hospital transfusion had early and late mortality similar to
patients not transfused pre-hospital.
Conclusions: These data suggest that early administration of plasma can provide significant hemostatic and potential
survival benefit to severely hemorrhaging trauma patients.
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Background
Death from injury has increased by 20% over the last dec-
ade and accounts for more deaths than malaria, tubercu-
losis and HIV combined [1]. Hemorrhage requiring
massive transfusion secondary to trauma remains a major
cause of potentially preventable deaths, and development
of trauma induced coagulopathy (TIC) further increases
the mortality rates of hemorrhaging patients substantially
[2]. During the last decade a number of strategies and pro-
tocols have been developed and adopted to improve the
management and delivery of care to trauma patients with
severe hemorrhage. These strategies include: (i) damage
control surgery, the use of abbreviated surgery to remedy
hemorrhage and contamination with definitive surgery de-
layed until physiology has been restored [3]; (ii) limited
use of crystalloid fluids, which can worsen coagulopathy
through dilution of clotting factors and platelets [4]; (iii)
hypotensive resuscitation, whereby normalization of blood
pressure is delayed until hemorrhage has been surgically
controlled [5]; and (iv) balanced blood product use,
whereby packed red blood cells (RBCs), plasma and plate-
lets are transfused in ratios of, or near to,1:1:1 mimicking
whole blood, which is associated with improved outcomes
and may help alleviate TIC [6, 7]. Taken together, these
are known as damage control resuscitation (DCR) [8]. As
DCR developed, it became clear that early, aggressive re-
suscitation with blood products could lead to early correc-
tion of acidosis, coagulopathy, and hypothermia [9–11].
Rawdan and colleagues reported that moving thawed
plasma from the blood bank to the emergency depart-
ment enabling early balanced blood product transfu-
sions, was associated with a reduction in overall blood
product use and a 60% decrease in odds of 30-day mor-
tality [12]. Based on this rapidly evolving experience, the
Texas Trauma Institute at Memorial Hermann Hospital
(Houston, TX) introduced the availability of two units of
O RhD negative RBCs and two units of thawed AB
plasma in appropriate temperature controlled containers
on four Life Flight (LF) helicopters [13]. Recently, we re-
ported that this novel practice of early hemostatic-
resuscitation with blood products was associated with
improved hemorrhage-resuscitation and patient out-
comes (i.e. improved survival) when compared to trauma
patients only receiving crystalloids en route to the hos-
pital [13].
The objective of the present observational study was
to investigate the association between pre-hospital ad-
ministered RBCs and plasma and hemostatic function as
evaluated by whole blood thrombelastography (TEG) on
arrival at the trauma center as compared to that of pa-
tients not receiving pre-hospital blood transfusions. We
hypothesized that patients receiving pre-hospital blood
products, specifically pre-hospital plasma, would display
improved hemostatic function as evaluated by TEG.
Methods
Setting and patients
The Texas Trauma Institute at Memorial Hermann Hos-
pital is an American College of Surgeons verified Level I
trauma center that is the primary teaching hospital for the
University of Texas Health Science Center and operates a
hospital-based helicopter program, Life Flight (LF). The
helicopters carry two units of type O RBCs and two units
of AB plasma for emergent use following established
guidelines. This prospective observational cohort study in-
cluded 257 trauma patients admitted directly from the
scene of the injury to the highest level of activation at Me-
morial Hermann Hospital Texas Medical Center (MHH-
TMC) between October 2012 and November 2013. The
University of Texas Health Science Center at Houston in-
stitutional review board (IRB) approved this study (IRB#
HSC-GEN-12-0059).
Patient selection
All adult trauma patients (≥16 years) who met criteria
for full trauma team activation and received blood be-
fore arrival at ED (i.e. pre-hospital, PH group) or after
hospital admittance within 6 h of ED arrival (i.e. in-
hospital, IH group) were included in this study.
The criteria for exclusion were: pregnancy, prisoner,
had a burned body surface area >20% or enrolled in an-
other study. Patients from whom we could not obtain a
blood draw were excluded from analysis. Informed con-
sent was obtained from the patient or a legally autho-
rized representative within 72 h of admission. If the
patients were discharged or died within 24 h, a waiver of
consent was granted. In cases which consent could not
be obtained, the patient was excluded from the study,
and their blood samples were destroyed. Patient infor-
mation on baseline demographics, clinical, physiologic,
and laboratory tests were extracted from patient records
and the institutional trauma registry.
Sample collection
Blood samples were collected immediately upon hospital
admission on all adult trauma patients (≥16 years) who
met criteria for full trauma team activation i.e., PH pa-
tients had samples drawn after PH blood transfusion
whereas IH patients had samples drawn before any
blood transfusion. In all cases, blood was drawn into
citrated tubes for conducing the rapid-TEG assay.
Rapid Thrombelastography (rTEG)
All rTEG specimens were run on a thrombelastograph
5000 (Haemoscope Corporation, Niles, IL). Admission
rTEGs were performed using the accepted citrate rever-
sal method. Specimens were collected in a small (3 mL)
citrated tube, transported to the Emergency Department
Stat Laboratory. The citrate was immediately reversed
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by adding calcium chloride according to the recommen-
dations of the manufacturer within the rTEG package
insert. After this, TEG was performed within 5–10 min
of blood sampling, using tissue factor and kaolin as acti-
vators. Staff laboratory technicians in the Memorial Her-
mann Hospital Emergency Department performed all
the rTEG assays during the defined study period. These
same technicians performed all the quality controls on
the TEG analyzers, doing so every 8 h. Quality control
was performed per the package insert from the
manufacturer.
The rTEG generates several values that describe the
hemostatic process: The first value generated is the acti-
vated clotting time (ACT), which is the time in seconds
between initiation of the test and the initial fibrin forma-
tion (normal range, 86–118 s). Similar to the ACT, the
r-value (also known as the reaction time (R-time), 0–1
min) expresses the time between the start of the assay
and beginning of clot formation. The K-time (normal
range, 1–2 min) is the time needed to reach 20-mm clot
strength and the alpha (α) angle (normal range, 66–82°)
determines the slope of the tracing that represents the
rate of clot formation. The maximal amplitude (MA;
normal range, 54–72 mm) is the greatest amplitude of
the tracing and the G-value (normal range, 5,300–12,000
dynes/cm2) is a global measure of absolute clot strength
(both enzymatic and platelet contributions) and is de-
creased in hypocoagulable states. LY30 (normal range,
0.0–7.5%) is the percent amplitude reduction at 30 min
after MA, illustrating the amount of fibrinolysis.
Statistics
Statistical analysis was performed using STATA (IC ver-
sion 12.1, College Station, TX) and SPSS 22 (IBM Cor-
poration, New York, US). Descriptive data are presented
as medians with inter quartile ranges (IQR) or as %
(proportions).
Non-parametric statistical tests (Mann-Whitney U test
and Kruskal-Wallis) and Chi-square tests were used to
evaluate group differences (PH vs. IH groups), as appro-
priate. P-values <0.05 were considered significant.
To investigate the association of pre-hospital RBCs
and plasma on admission for rTEG MA, a parameter
with significant predictive value for transfusion require-
ments and mortality [14–16], we conducted a linear re-
gression analysis. Univariate and multivariate linear
regression models were constructed for each group (PH,
IH) and combined including both groups. Multivariate
linear regression models were adjusted for admission
vital differences between the PH and IH groups (systolic
blood pressure (SBP), hemoglobin, platelet count and
pH) as well as adjusting for mode of transport (i.e. LF or
ambulance) and amount of PH-RBC and PH-Plasma in
the model including both groups (PH and IH).
Furthermore we compared rTEG parameters in PH pa-
tients receiving plasma based on the amount adminis-




A total of 257 patients were included in the study, 75 (29%)
patients received pre-hospital (PH) blood, whereas 182
(71%) patients only received blood in-hospital (IH) within
6 h of hospital admission. Eighty-six patients were trans-
ported by ground ambulance and 171 patients by LF, of
which 44% received a PH blood transfusion (Table 1). The
median age of the study cohort was 37 years, 81% were
male, with a median injury severity score (ISS) of 26
(Table 1). Patients in the PH group demonstrated a higher
incidence of penetrating injuries (45 vs. 25%, p = 0.002),
field intubations (39 vs. 21%, p = 0.005), positive FAST
exams and presented with lower GCS scores compared to
patients in the IH group (Table 1). Additionally, patients re-
ceiving PH blood displayed significantly lower systolic
blood pressure (SBP), hemoglobin, platelet count and more
acidosis than IH, suggesting a more pronounced degree of
hemorrhage and/or shock in the PH group. Lastly, patients
receiving PH blood received more units of blood products
within 6 and 24 h after admission (Table 1). Despite differ-
ences in type of injury and admission vitals indicating more
severe injury and bleeding in the PH group, there were no
significant differences in mortality (Table 1).
Pre-hospital Plasma is associated with improved
hemostasis
Despite the variations between the two groups, no signifi-
cant differences were found in the median rTEG values,
respectively for the PH vs. IH, for ACT (121 vs. 121), R-
time (0.8 vs. 0.8), K-time (1.65 vs. 1.45), Angle (70 vs. 73)
and Ly30 (1 vs. 1.4), upon arrival at the hospital. However,
at hospital admission PH displayed significant lower me-
dian rTEG MA (62 vs. 64, P = 0.020) and G-value (8.1 vs.
8.69, P = 0.009) compared to IH patients. Table 2 shows
the distribution of pre-hospital blood products transfused.
Nearly half of the PH group received 1 unit of RBCs and
plasma each (Table 2). When comparing rTEG values
ACT, R-time, K-time, α-Angle, MA, G and LY30 in PH pa-
tients receiving 0, 1 and 2 units of plasma pre-hospital un-
adjusted for PH RBC, patients receiving 2 units of plasma
pre-hospital had the highest mean values of rTEG α-Angle
(70.57 vs. 67.51 vs. 72.00° for plasma = 0, 1 and 2 units, re-
spectively), rTEG MA (58.73 vs. 57.30 vs. 62.55 mm for
plasma = 0, 1 and 2 units, respectively) and rTEG G (5.93
vs. 7.36 vs. 8.41 dyn/cm2 for plasma = 0, 1 and 2 units, re-
spectively). Furthermore, patients receiving 2 units of
plasma pre-hospital had lower average values of K-time
(1.63 vs. 2.07 vs. 1.59 min for plasma = 0, 1 and 2 units,
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respectively) and R-time (2.07 vs. 1.07 vs. 0.72 min for
plasma = 0, 1 and 2 respectively). There was a significant
difference in R-time between patients receiving no pre-
hospital plasma compared to patients receiving 2 units of
plasma (P = 0.023).
Predictors of hemostatic competence
In the PH group, the unadjusted univariate linear regres-
sion demonstrated that pre-hospital plasma was








Age Years 37 (25, 53) 34 (23, 53) 39 (26, 53) 0.259
Male n (%) 208 (80.9%) 62 (82.7%) 146 (80.2%) 0.650
Injury Scores and severity
ISS Score 26 (17, 34) 29 (17, 41) 26 (17, 34) 0.106
GCS Score 10 (3, 15) 3 (3, 15) 12 (3, 15) 0.022
Positive FAST % 54 (31.4%) 26 (48.1%) 28 (23.7%) 0.001
Penetrating Injury % 80 (31.1%) 34 (45.3%) 46 (25.3%) 0.002
Intubated in the field % 63 (27.2%) 29 (39.2%) 34 (21.5%) 0.005
Admission Vitals
SBP mmHg 98 (80, 123) 90 (77, 113) 100 (80, 125) 0.044
DBP mmHg 60 (48, 74) 59 (50, 69) 60 (48, 76) 0.299
Heart rate Bpm 108 (88, 130) 111 (90, 133) 108 (85, 130) 0.425
Hemoglobin g/dL 12.9 (11.3, 14.2) 12.4 (11.3, 13.4) 13.1 (11.35, 14.3) 0.011
Platelet count x103/μL 215 (163, 250) 193 (152, 223) 225 (174, 257) 0.001
pH 7.26 (7.15, 7.32) 7.21 (7.06, 7.32) 7.27 (7.18, 7.33) 0.002
Base Excess mEq/L −5 (−10, −2) −6 (−10, −3) −4 (−10, −1) 0.073
Mode of Transport
LF % 171 (66.8%) 75 (100%) 96 (52.7%) <0.001
Transfusion: Prehospital
RBC Units 0 (0, 0) 1 (1, 2) 0 (0, 0) NA
Plasma Units 0 (0, 0) 1 (1, 2) 0 (0, 0) NA
Transfusion: Admission - 6 h total transfusions
RBC Units 4 (2, 10) 8 (4, 14) 3 (1, 8) <0.001
Plasma Units 4 (2, 8) 6 (3, 12) 3 (2, 7) <0.001
Platelets Packs 0 (0, 6) 6 (0, 12) 0 (0, 6) <0.001
Transfusion: Admission - 24 h total transfusions
RBC Units 5 (2, 12) 10 (4, 15) 4 (2, 9) <0.001
Plasma Units 4 (2, 9) 7 (3, 14) 4 (2, 8) <0.001
Platelets Packs 6 (0, 12) 6 (0, 18) 0 (0, 6) <0.001
Outcomes
6-h mortality % 25 (9.7%) 10 (13.3%) 15 (8.2%) 0.210
24-h mortality % 31 (12%) 12 (16%) 19 (10.4%) 0.213
In-hospital mortality % 58 (22.6%) 20 (26.7%) 38 (20.9%) 0.313
Patients met criteria for full trauma team activation and either received blood before arrival at ED (PH) or in the first 6 h after hospital admission (IH). Medians
(IQR) or n (%) are reported
All the bold numbers reflect data that is significant
Table 2 Distribution of patients receiving pre-hospital blood products
Plasma
0 U 1 U 2 U Total RBC
0 U 0 (0%) 10 (13%) 3 (4%) 13 (17%)
RBC 1 U 2 (3%) 30 (40%) 7 (9%) 39 (52%)
2 U 1 (1%) 2 (3%) 20 (27%) 23 (31%)
Total Plasma 3 (4%) 42 (56%) 30 (40%) 75 (100%)
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associated with significantly higher rTEG MA values
(one unit increase in PH plasma was associated with (β
coefficient) 13.95 mm, 95%CI [3.13, 24.77], p = 0.012)
higher MA at hospital admission in a model only adjust-
ing for PH RBC. The interaction between PH RBC and
plasma did not appear to have a significant effect on ad-
mission rTEG MA values (data not shown). When
adjusting for pH, hemoglobin, platelet count, SBP, and in
PH patients PH-RBC and PH-Plasma, higher pH and
higher platelet count were independent predictors of
rTEG MA in IH patients and higher pH, higher platelet
count and PH-Plasma were associated with higher rTEG
MA in PH patients (all p < 0.05, data not shown).
When conducting the analysis non-stratified (including
both PH and IH groups in the same analysis), and in-
stead adjusting for transportation (by LF or ambulance)
and admission vital differences, and PH transfusion with
Plasma and RBC, PH plasma transfusions were associ-
ated independently with higher rTEG MA values to-
gether with higher pH, higher SBP and higher platelet
count (Table 3).
Discussion
This study found that after adjusting for pre-hospital
RBCs, pre-hospital plasma transfusion was independ-
ently associated with increased rTEG MA, as well as ar-
rival indices of shock and hemodynamic instability.
Acidosis and low platelet count were found to impede
hemostatic potential evaluated by rTEG. Besides more
severe injury and worse clinical presentation, the group
that received pre-hospital transfusion had early and late
mortality similar to patients not transfused pre-hospital.
Reduced clot strength, as evaluated by TEG, has re-
peatedly been associated with increased bleeding, trans-
fusion requirements and mortality in severely injured
trauma patients [16, 17]. In the present study, plasma
transfusion PH was independently associated with higher
rTEG MA values, also after adjusting for pre-hospital
RBCs. Furthermore, patients in the PH group receiving
the highest amount of pre-hospital plasma transfusions
differed in their hemostatic competence as evaluated by
rTEG when compared to the patients in the PH group
only receiving one or zero pre-hospital plasma. Given
that the most severely injured and bleeding patients are
expected to receive the highest amount of plasma pre-
hospital, this suggests that pre-hospital plasma is more
beneficial than pre-hospital RBCs for improving
hemostasis in the acute/pre-hospital setting, in accord-
ance with the coagulation factor and fibrinogen content
in plasma compared to RBC.
Furthermore, PH patients were significantly different
from IH patients. PH patients presented with more
penetrating injuries, more positive FAST exams, lower
systolic blood pressures, lower hemoglobin, lower plate-
let count, lower pH upon arrival to the trauma bay and
lower rTEG MA and G, despite receiving pre-hospital
RBC and/or plasma transfusions during transport. How-
ever, 52.7% of the IH patients were transported by LF
where blood products are available; indicating that the
prehospital blood transfusion by LF was not deemed ne-
cessary for these patients as they were not transfused.
Furthermore, IH patients only received three RBCs and
three plasma units within six hours of hospital admis-
sion, which suggests only moderate hemorrhage com-
pared to eight RBCs and six plasma units in the PH
group. Due to these differences, we stratified by group
as well as conducting adjusted regression analyses. Re-
gardless of group, however, acidosis and low platelet
count were the strongest predictors of reduced
hemostatic competence evaluated by rTEG MA values.
This indicates that future analyses of rTEG should con-
sider adjusting for pH and platelet count to make appro-
priate comparisons.
In addition, the acid buffer capacity of plasma is
known to be 25–50 times better than crystalloids solu-
tions [18], and despite the divergence between the two
groups, the data shows no significant difference in the 6-h,
24-h, and the overall mortality. This indicates that pre-
hospital plasma transfusion may lead to early correction
of acidosis thereby mitigating coagulopathy, which
Table 3 Admission rapid thrombelastography (rTEG) MA-value evaluated by linear regression in 257 adult trauma patients
Variable Units Univariate Adjusted
β (95% CI) P value β (95% CI) P value
LF Yes −0.52 (−3.25, 2.21) 0.709 1.02 (−1.41, 3.46) 0.408
pH mEq/l 30.00 (21.53, 38.47) <0.001 23.55 (15.26, 31.8) <0.001
Hemoglobin g/dl 0.80 (0.19, 1.42) 0.011 −0.12 (−0.68, 0.43) 0.666
Platelet counts 103/μL 0.07 (0.05, 0.08) <0.001 0.06 (0.04, 0.08) <0.001
SBP mmHg 0.07 (0.04, 0.11) <0.001 0.04 (0.00, 0.07) 0.047
PH-RBC units −1.89 (−3.86, 0.09) 0.061 −1.82 (−4.82, 1.18) 0.232
PH-Plasma units −0.85 (−2.68, 0.99) 0.364 2.88 (0.10, 5.66) 0.042
Regression coefficients (β) with 95% confidence intervals (95% CI) and p-values are displayed. P-values <0.05 are shown in bold. Predicted change in rTEG MA
(mm) associated with: LF (yes) and one unit higher pH, Hemoglobin, Platelet count, SBH, PH-RBC and PH-Plasma
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potentially can be translated into improved survival
though this has to be investigated in future studies de-
signed specifically to answer this question.
The study has several limitations. First, it should be
noted that we could not obtain blood samples from “in-
the-field”, prior to when the patient received pre-
hospital transfusions. As such, we cannot definitively as-
sess the effect of each transfusion and potential changes
in the TEG values from “in-the-field” vs. hospital admis-
sion. Future studies are needed to evaluate these prehos-
pital and pre-transfusion acute changes in clotting
properties. Furthermore, another limitation is the rela-
tively small sample size of 75 patients within the PH
group and nearly half of these patients received one unit
of RBCs and plasma pre-hospital. This emphasize the
need for future studies investigating the relative benefits
of adding RBCs to plasma in a larger number of patients,
preferably sampling blood for pre-hospital analysis.
Conclusion
In conclusion, after adjusting for pre-hospital RBCs, pre-
hospital plasma transfusion was independently associated
with higher rTEG MA. Acidosis (low pH levels) and low
platelet counts were the strongest predictors of poor
hemostasis evaluated by rTEG. Besides, more severe injury
and worse clinical presentation, the PH group had early
and late mortality similar to the IH group. Overall, these
data imply that early administration of plasma may have
beneficial effects on improving hemostasis, which may po-
tentially translate into improved patient survival in future
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